HETEROCYCLIC COMPOUND Application WO-2024033845-A1 World Intellectual Property Organisation (WIPO) 15 Feb 2024
DOSING REGIMEN FOR A NLRP3 INHIBITOR Application WO-2024023696-A1 World Intellectual Property Organisation (WIPO) 01 Feb 2024
Protection of cells from degeneration and treatment of geographic atrophy Grant US-11883409-B2 United States of America 30 Jan 2024